DAVID L HUDSON
Allopathic & Osteopathic Physicians|Family Medicine GREER, SC NPI 1104897891
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine SC Amgen Inc. All categories
General Payments — all program years on this page
$230.68
- Category: General Payments
- Program years: PY2020–2024
- Record count: 14
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $130.65 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $130.65 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $35.62 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $34.33 | 2 |
| Novo Nordisk AS | $32.79 | 2 |
| ABBVIE INC. | $27.91 | 2 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1086955527 | Novartis Pharmaceuticals Corporation | $14.16 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1086955539 | Novartis Pharmaceuticals Corporation | $20.17 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1096590005 | Novo Nordisk Inc | $13.20 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1097596797 | Novo Nordisk Inc | $19.59 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1103950278 | ABBVIE INC. | $13.46 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1103950280 | ABBVIE INC. | $14.45 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117282177 | Amgen Inc. | $17.80 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117282179 | Amgen Inc. | $17.82 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.